Literature DB >> 8603956

Determinants of persistent detection of human papillomavirus DNA in the uterine cervix.

J Brisson1, I Bairati, C Morin, M Fortier, C Bouchard, A Christen, P Bernard, M Roy, A Meisels.   

Abstract

To identify factors associated with persistence of human papillomavirus (HPV) DNA in the uterine cervix, 179 women who were 18-49 years old and who had normal cytologies and positive cervical HPV DNA test at a routine periodic examination were analyzed. Among them, 91 (50.8%) remained HPV-positive a few months (mean, 11 weeks) later. Persistence was higher in women who had used oral contraceptives for > or = 2 years (odds ratio, 3.9; 95% confidence interval, 1.5-10.3) compared with those who never used oral contraceptives or used them for <2 years. HPV types 16, 18, and 31/33/35 appeared more persistent (odds ratio, 2.5; 95% confidence interval, 1.0-6.2) than other types. Persistence seemed to increase with virus load and decrease with increasing interval between examinations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603956     DOI: 10.1093/infdis/173.4.794

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

2.  Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research.

Authors:  H Baer; S Allen; L Braun
Journal:  J Community Health       Date:  2000-02

3.  Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study.

Authors:  Su-Hsun Liu; Rebecca M Brotman; Jonathan M Zenilman; Patti E Gravitt; Derek A T Cummings
Journal:  J Infect Dis       Date:  2013-07-24       Impact factor: 5.226

4.  A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.

Authors:  Darron R Brown; Marcia L Shew; Brahim Qadadri; Nicole Neptune; Maria Vargas; Wanzhu Tu; Beth E Juliar; Timothy E Breen; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2004-12-10       Impact factor: 5.226

Review 5.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

6.  Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Authors:  Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

7.  Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated.

Authors:  Amanda F Dempsey
Journal:  Rev Obstet Gynecol       Date:  2008

8.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

9.  Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision.

Authors:  A L Distéfano; M A Picconi; L V Alonio; D Dalbert; J Mural; O Bartt; G Bazán; G Cervantes; M Lizano; A G Carrancá; A Teyssié
Journal:  Infect Dis Obstet Gynecol       Date:  1998

10.  HPV prevalence and concordance in the cervix and oral cavity of pregnant women.

Authors:  E M Smith; J M Ritchie; J Yankowitz; D Wang; L P Turek; T H Haugen
Journal:  Infect Dis Obstet Gynecol       Date:  2004-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.